EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company commercializing and developing topical non-antibiotic antimicrobial products for the global eye care market, announces that it has rescheduled the date to report third quarter financial results and hold an investment community conference call to Monday, November 16, from the previously announced date of Friday, November 13.
Help employers find you! Check out all the jobs and post your resume.
